Bambusa Therapeutics, Inc. (BBTX)
NASDAQ: BBTX · Real-Time Price · USD
17.16
+0.11 (0.65%)
Nov 11, 2026, 4:00 PM EST - Market closed
Bambusa Therapeutics Market Cap
Bambusa Therapeutics has a market cap or net worth of $874.17 million as of November 11, 2026. It is the 10,855th most valuable company in the world and the 2,327th biggest in the United States.
Market Cap
874.17M
Enterprise Value
802.70M
1-Year Change
n/a
Global Rank
Country Rank
#2,327 United States
Category
ChartMarket Cap Chart
Since the IPO on October 30, 2026, Bambusa Therapeutics's market cap has increased from $796.19M to $874.17M, an increase of 9.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 874.17M | 0.65% |
| Nov 10, 2026 | 868.57M | 0.65% |
| Nov 9, 2026 | 862.96M | 7.69% |
| Nov 6, 2026 | 801.32M | -0.76% |
| Nov 5, 2026 | 807.44M | -1.37% |
| Nov 4, 2026 | 818.64M | 0.44% |
| Nov 3, 2026 | 815.08M | - |
| Nov 2, 2026 | 815.08M | 2.37% |
| Oct 30, 2026 | 796.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 922.51M |
| Immatics | 914.46M |
| Pharming Group | 905.39M |
| Inventiva | 872.93M |
| Monte Rosa Therapeutics | 872.45M |
| Syndax Pharmaceuticals | 868.77M |
| Alumis | 855.57M |
| Solid Biosciences | 852.70M |